Colonization of residents and staff of an Italian long-term care facility and an adjacent acute care hospital geriatric unit by multidrug-resistant bacteria.

In 2016, we undertook a point prevalence screening study for Enterobacteriaceae with extended-spectrum β-lactamases (ESBLs), high-level AmpC cephalosporinases and carbapenemases, and also methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin resistant enterococci (VRE) in a long-term care facility (LTCF) and the associated acute care hospital geriatric unit in Bolzano, Northern Italy. Urine samples and rectal, inguinal, oropharyngeal and nasal swabs were plated on selective agars. Demographic data were collected. ESBL and carbapenemase genes were sought by PCR. We found the following colonization percentages with multidrug-resistant (MDR) bacteria in 2016 in LTCF residents: all MDR organisms, 66.1%; ESBL producers, 53.0%; carbapenemase-producers, 1.7%; MRSA, 14.8%; VRE, 0.8%. Colonization by all MDR bacteria was 19.4% for LTCF staff and 26.0% for geriatric unit patients. PCR showed that 80.3% of Escherichia coli isolates from LTCF residents, all E. coli isolates from LTCF staff, 62.5% and 100% of Klebsiella pneumoniae from LTCF residents and geriatric unit patients, respectively, had a blaCTX-M-type gene. All carbapenemase-producing Enterobacteriaceae harboured a blaVIM-type gene. To conclude, the ongoing widespread diffusion of MDR bacteria in the LTCF suggests that efforts should be strengthened on MDR screening, implementation of infection control strategies and antibiotic stewardship programs targeting the unique aspects of LTCFs.

[1]  A. Pantosti,et al.  Colonization by multidrug-resistant organisms in long-term care facilities in Italy: a point-prevalence study. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[2]  M. Confalonieri,et al.  Review on colonization of residents and staff in Italian long-term care facilities by multidrug-resistant bacteria compared with other European countries , 2016, Antimicrobial Resistance & Infection Control.

[3]  A. Piazza,et al.  Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy. , 2016, Advances in experimental medicine and biology.

[4]  M. Triassi,et al.  Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d’Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789) , 2015, BMC Microbiology.

[5]  L. Mody,et al.  Colonization with Multidrug-Resistant Organisms in Nursing Homes: Scope, Importance, and Management , 2015, Current Geriatrics Reports.

[6]  A. Pantosti,et al.  Emergence of Escherichia coli ST131 sub-clone H30 producing VIM-1 and KPC-3 carbapenemases, Italy. , 2014, The Journal of antimicrobial chemotherapy.

[7]  N. Woodford,et al.  Changes in colonization of residents and staff of a long-term care facility and an adjacent acute-care hospital geriatric unit by multidrug-resistant bacteria over a four-year period , 2014, Scandinavian journal of infectious diseases.

[8]  G. Rossolini,et al.  Carbapenemase-producing Enterobacteriaceae during 2011-12 in the Bolzano area (Northern Italy): increasing diversity in a low-endemicity setting. , 2013, Diagnostic microbiology and infectious disease.

[9]  M. Moro,et al.  Antimicrobial resistance and stewardship in long-term care settings. , 2013, Future microbiology.

[10]  A. Agodi,et al.  Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities , 2013, BMC Infectious Diseases.

[11]  V. Sambri,et al.  Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  N. Woodford,et al.  Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  N. Woodford,et al.  Metallo-β-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008: Metallo-β-lactamases among Enterobacteriaceae from routine samples , 2011 .

[14]  N. Woodford,et al.  Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids encoding KPC enzymes in the USA. , 2010, The Journal of antimicrobial chemotherapy.

[15]  N. Woodford,et al.  Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  A. Pantosti,et al.  Meticillin-resistant Staphylococcus aureus colonising residents and staff members in a nursing home in Northern Italy. , 2009, Journal of Hospital Infection.

[17]  V. Miriagou,et al.  Emerging Klebsiella pneumoniae Isolates Coproducing KPC-2 and VIM-1 Carbapenemases , 2009, Antimicrobial Agents and Chemotherapy.

[18]  G. Palù,et al.  Clustering and Risk Factors of Methicillin-Resistant Staphylococcus aureus Carriage in Two Italian Long-Term Care Facilities , 2009, Infection.

[19]  Philip Smith,et al.  SHEA/APIC Guideline: Infection prevention and control in the long-term care facility , 2008, American Journal of Infection Control.

[20]  A. Vatopoulos,et al.  Extended-spectrum beta-lactamase types in Klebsiella pneumoniae and Escherichia coli in two Greek hospitals. , 2003, International journal of antimicrobial agents.

[21]  Thierry Naas,et al.  Characterization of VIM-2, a Carbapenem-Hydrolyzing Metallo-β-Lactamase and Its Plasmid- and Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in France , 2000, Antimicrobial Agents and Chemotherapy.